TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
Open accessThe DOI matches its Crossref record; 55 of the 57 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Tumor necrosis factor-α (TNF-α) and interleukin-1 beta (IL-1β) are elevated in the vitreous of diabetic patients and in retinas of diabetic rats associated with increased retinal vascular permeability. However, the molecular mechanisms underlying retinal vascular permeability induced by these cytokines are poorly understood. In this study, the effects of IL-1β and TNF-α on retinal endothelial cell permeability were compared and the molecular mechanisms by which TNF-α increases cell permeability were elucidated. RESEARCH DESIGN AND METHODS: Cytokine-induced retinal vascular permeability was measured in bovine retinal endothelial cells (BRECs) and rat retinas. Western blotting, quantitative real-time PCR, and immunocytochemistry were performed to determine tight junction protein expression and localization. RESULTS: IL-1β and TNF-α increased BREC permeability, and TNF-α was more potent. TNF-α decreased the protein and mRNA content of the tight junction proteins ZO-1 and claudin-5 and altered the cellular localization of these tight junction proteins. Dexamethasone prevented TNF-α–induced cell permeability through glucocorticoid receptor transactivation and nuclear factor-kappaB (NF-κB) transrepression. Preventing NF-κB activation with an inhibitor κB kinase (IKK) chemical inhibitor or adenoviral overexpression of inhibitor κB alpha (IκBα) reduced TNF-α–stimulated permeability. Finally, inhibiting protein kinase C zeta (PKCζ) using both a peptide and a novel chemical inhibitor reduced NF-κB activation and completely prevented the alterations in the tight junction complex and cell permeability induced by TNF-α in cell culture and rat retinas. CONCLUSIONS: These results suggest that PKCζ may provide a specific therapeutic target for the prevention of vascular permeability in retinal diseases characterized by elevated TNF-α, including diabetic retinopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These molecules function to promote leukocyte recruitment, adhesion, and infiltration through the blood-retinal barrier, ultimately resulting in a breakdown of retinal immune privilege.15,16”
From Characterizing the cellular immune response to subretinal AAV gene therapy in the murine retina (2021) · cites this paper as [15]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, neurovascular damage induced by the peripheral myeloid cells, pro-inflammatory cytokines, and the dysregulation of the complement pathways could be a further potential mechanism of action [36,37,38].”
From C-Reactive protein as a biomarker for major depressive disorder? (2022) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · cited 1×
“0 RQ software and the 2 Ct analysis method (31), with glyceraldehyde-3-phosphate dehydrogenase (Bt03210919_g1) as the endogenous control.”
MethodBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 1×
“Gene deletion studies have shown claudin-5 to be essential for blood–brain barrier function (25), and likely for the BRB as well.”
BackgroundSignalling to and from tight junctions
Matter, K., & Balda, M. S. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1055 · Cited by 884 · cited 1×
“Tight junctions are composed of a combination of more than 40 proteins including the transmembrane proteins occludin, the claudin family, and the junction adhesion molecule (JAM) family, several peripheral membrane-associated proteins, including members of the zonula occludens (ZO) family, and several regulatory prote…”
BackgroundUmeda, K., Ikenouchi, J., Katahira-Tayama, S., Furuse, K., Sasaki, H., Nakayama, M., Matsui, T., Tsukita, S., Furuse, M., & Tsukita, S. (2006) · Cell · doi:10.1016/j.cell.2006.06.043 · Cited by 823 · cited 1×
“Recent studies demonstrated that ZO proteins are essential for the formation and organization of tight junction complex assembly (26,27).”
BackgroundMiyamoto, K., Khosrof, S., Bursell, S.-E., Rohan, R., Murata, T., Clermont, A. C., Aiello, L. P., Ogura, Y., & Adamis, A. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10836 · Cited by 788
Antonetti, D. A., Barber, A. J., Bronson, S. K., Freeman, W. M., Gardner, T. W., Jefferson, L. S., Kester, M., Kimball, S. R., Krady, J. K., LaNoue, K. F., et al. (2006) · Diabetes · doi:10.2337/db05-1635 · Cited by 746
Self-citationAntonetti, D. A., Barber, A. J., Hollinger, L. A., Wolpert, E. B., & Gardner, T. W. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.33.23463 · Cited by 686
Self-citationIkenouchi, J., Matsuda, M., Furuse, M., & Tsukita, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00389 · Cited by 678
The 14-year incidence of visual loss in a diabetic population,
Moss, S. (1998) · Ophthalmology · doi:10.1016/s0161-6420(98)96025-0 · Cited by 672
Cited by
Items 401–410 of 410
Lim, J. X., Yong, P. H., & Ng, Z. X. (2026) · Phytochemistry Reviews · doi:10.1007/s11101-026-10270-6
“TNF-a has been shown to increase retinal endothelial permeability by down-regulating tight junction proteins, thereby compromising the integrity of the blood–retinal barrier (Aveleira et al. 2010).”
Beyond hyperglycaemia: diabetic retinopathy is a multifactorial complication of diabetes mellitus
Zou, Y., Yang, H., Lin, Y., Li, Q., Bao, Y., & Du, X. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2698364
Noma, H., & Mimura, T. (2026) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2026.2720412
“Experimental studies have shown that IL-6 downregulates the expression of key tight junction proteins, including occludin, claudin-5, and ZO-1, in retinal vascular endothelial cells [29].”
Xu, J., Tan, Y., Huang, Z., Wang, X., Song, L., Xing, J., Li, R., & Yi, J. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02427-7
“…NF-κB sig - naling pathway, which on the one hand downregulates tight junction proteins such as zonula occludens-1 (ZO-1) and Claudin-5 and promotes their redistribution from the membrane to the cytoplasm, thereby disrupting vascular barrier integrity and increasing endothelial permeability [40].”
InfluentialRetinal Inflammation in Diabetes
la Huerta, I. D., Uddin, M. I., Muthiah, M. N., & Penn, J. S. (2026) · American Journal Of Pathology · doi:10.1016/j.ajpath.2026.08.004
Immunocytokines in cancer: a safety perspective
Prajapati, K., Betts, C. J., & Stebbings, R. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1894312
Metadata
- Authors
- Aveleira, C. A., Lin, C.-M., Abcouwer, S. F., Ambrósio, A. F., & Antonetti, D. A.
- Affiliations
- Pennsylvania State University (US)
- Centro de Neurociências e Biologia Celular (PT)
- Corresponding author
- Aveleira, Célia A.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2010-08-06
- Volume
- 59
- Issue
- 11
- Pages
- 2872-2882
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2963546
- OpenAlex
- W2155144135
- Cited by
- 403
- References
- 57
- Citations by year
- 2026: 18 · 2025: 25 · 2024: 17 · 2023: 26 · 2022: 31 · 2021: 33 · 2020: 34 · 2019: 35 · 2018: 35 · 2017: 31 · 2016: 23 · 2015: 29 · 2014: 17 · 2013: 21 · 2012: 20
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Juvenile Diabetes Research Foundation International
- University of Pennsylvania
- Pennsylvania State University
- National Institutes of Health (012021)
- Penn State College of Medicine
- National Eye Institute (R01EY012021, R01EY016413)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Keywords
- TNF-α, IL-1β, tight junction proteins, ZO-1, claudin-5, protein kinase C, NF-κB signaling, dexamethasone, glucocorticoid receptor, IκBα, diabetic retinopathy, retinal vascular permeability, IKK inhibitor
- MeSH terms
- Protein Kinase C zeta, Animals, Cattle, Cell Membrane Permeability, Dexamethasone, Diabetic Retinopathy, Humans, Male, Permeability, Protein Kinase C, Retina, Retinal Diseases, Tumor Necrosis Factor-alpha, NF-kappa B, Rats, Sprague-Dawley, Tight Junctions, Endothelial Cells, Rats, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.